These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24933028)

  • 1. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant.
    Mai S; Lin L; Yang W; Deng X; Xie Z; Zong Y; Li Y; Gao Q
    J Ocul Pharmacol Ther; 2014 Oct; 30(8):670-80. PubMed ID: 24933028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
    Okabe K; Kimura H; Okabe J; Ogura Y
    Retina; 2007; 27(6):770-7. PubMed ID: 17621189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits.
    Fujita E; Teramura Y; Shiraga T; Yoshioka S; Iwatsubo T; Kawamura A; Kamimura H
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):309-19. PubMed ID: 18476801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
    Kim H; Csaky KG; Gilger BC; Dunn JP; Lee SS; Tremblay M; de Monasterio F; Tansey G; Yuan P; Bungay PM; Lutz RJ; Robinson MR
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):655-62. PubMed ID: 15671296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.
    Yuan J; Zhai JJ; Chen JQ; Ye CT; Zhou SY
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):345-50. PubMed ID: 19492954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S; Bezwada P; Takanaga H; Hosoi K; Tsuboi T; Ueda K; Kawazu K; Ali Y; Naor J
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):507-14. PubMed ID: 22662868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection.
    Lee SS; Kim H; Wang NS; Bungay PM; Gilger BC; Yuan P; Kim J; Csaky KG; Robinson MR
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2023-9. PubMed ID: 17460256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.
    Okabe J; Kimura H; Kunou N; Okabe K; Kato A; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):740-4. PubMed ID: 12556407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus.
    Zhang J; Liu Z; Tao C; Lin X; Zhang M; Zeng L; Chen X; Song H
    Eur J Pharm Sci; 2020 Mar; 144():105229. PubMed ID: 31958581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Biodegradable, Sustained-Released, Tacrolimus Microfilm Drug Delivery System for the Management of Allergic Conjunctivitis in a Mouse Model.
    Liu YC; Ng XW; Teo EPW; Ang HP; Lwin NC; Chan NSW; Venkatraman SS; Wong TT; Mehta JS
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):675-684. PubMed ID: 29392313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device.
    Okabe K; Kimura H; Okabe J; Kato A; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2702-7. PubMed ID: 12766076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
    Shi WY; Liu T; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery from episcleral exoplants.
    Pontes de Carvalho RA; Krausse ML; Murphree AL; Schmitt EE; Campochiaro PA; Maumenee IH
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4532-9. PubMed ID: 17003449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.